DistantNews
Support us
🇫🇯 Fiji /Technology

Investors are underestimating AI’s power to transform lives

From FBC News · () English

Translated from English and summarized by DistantNews. Read the original for the full story.

At a glance

Interview Named sources Context piece
  • Cathie Wood says investors are overlooking the potential of embodied AI, including autonomous vehicles and humanoid robots.
  • She identifies health care as AI’s biggest transformative opportunity, citing faster drug discovery, early diagnosis and gene editing.
  • Wood estimates AI could reduce drug-development timelines from about 13 years to five and costs from $2.4 billion to $600 million-$700 million.

Cathie Wood says the most important part of artificial intelligence may not be inside a data centre. The ARK Invest chief executive argues that investors are still underestimating “embodied AI,” in which software operates through physical systems such as vehicles and robots.

Wood made the comments during a visit to Australia, where a humanoid robot from Xpeng was displayed at a launch event in Melbourne. She said investors understood the opportunity in data centres, but had not fully priced the potential of physical AI. ARK’s largest holding remains Tesla, which she calls “the biggest AI project on Earth.” The fund holds more than $1.6 billion in Tesla shares, about a tenth of its portfolio.

What’s underappreciated, in terms of AI, is what we call embodied AI or physical AI.

· Cathie WoodWood said investors focused too heavily on data centres and were overlooking AI’s physical applications.

Wood forecasts annual revenue of $10 trillion from autonomous transportation within five to 10 years, including the wider ecosystem and China. She puts the potential annual market for humanoid robots in homes and factories at $25 trillion. Tesla’s humanoid robot could reach consumers in 2027, she said.

Autonomous transportation, we think, is going to deliver revenues within the next five to 10 years of $US10 trillion ($14 trillion) per year.

· Cathie WoodShe described her forecast for the autonomous-transportation ecosystem.

Health care, however, is where Wood sees AI making its biggest difference. She says the technology could shorten the search for new drugs and therapies and use blood tests to identify diseases before symptoms appear. She also points to gene-editing company CRISPR Therapeutics, which is treating sickle cell disease and beta thalassemia and is pursuing a therapy for high cholesterol.

Drug development now takes about 13 years and costs $2.4 billion, according to the figures cited by Wood. She believes AI could cut that process to five years and $600 million to $700 million. ARK has also invested in companies using AI to develop treatments for endometriosis and alopecia.

We think that AI is going to collapse the time and the cost to discover new drugs and therapies.

· Cathie WoodWood identified health care as the most transformative area for AI.
About this summary

Originally published by FBC News in English. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.

More Stories

From Our Blog